Your browser doesn't support javascript.
loading
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Ruan, Jia; Moskowitz, Alison; Mehta-Shah, Neha; Sokol, Lubomir; Chen, Zhengming; Kotlov, Nikita; Nos, Grigorii; Sorokina, Maria; Maksimov, Vladislav; Sboner, Andrea; Sigouros, Michael; van Besien, Koen; Horwitz, Steven; Rutherford, Sarah C; Mulvey, Erin; Revuelta, Maria V; Xiang, Jenny; Alonso, Alicia; Melnick, Ari; Elemento, Olivier; Inghirami, Giorgio; Leonard, John P; Cerchietti, Leandro; Martin, Peter.
Afiliação
  • Ruan J; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Moskowitz A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Mehta-Shah N; Washington University in St. Louis, St. Louis, MO.
  • Sokol L; Moffitt Cancer Center, Tampa, FL.
  • Chen Z; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Kotlov N; BostonGene Corporation, Waltham, MA.
  • Nos G; BostonGene Corporation, Waltham, MA.
  • Sorokina M; BostonGene Corporation, Waltham, MA.
  • Maksimov V; BostonGene Corporation, Waltham, MA.
  • Sboner A; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Sigouros M; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • van Besien K; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Horwitz S; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Rutherford SC; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Mulvey E; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Revuelta MV; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Xiang J; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Alonso A; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Melnick A; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Elemento O; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Inghirami G; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Leonard JP; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Cerchietti L; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
  • Martin P; Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.
Blood ; 141(18): 2194-2205, 2023 05 04.
Article em En | MEDLINE | ID: mdl-36796016
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article